Pharmacology & Toxicology Webinars

Join Michiel Helmes and Diederik Kuster as they demonstrate best practices and new techniques in high-content, higher throughput investigations of excitation-contraction coupling in isolated cardiomyocytes.

OBESITY SERIES 2020: Dr. Ania Jastreboff discusses the current use of anti-obesity pharmacotherapy, mechanisms involved, and agents in various stages of development with considerations for next steps.

Joanna Moore and Kenneth Dyar present applications of the DVC® system from different research perspectives and discuss how home cage monitoring can be used to study animal model development, physiology and behavior

Dr. Malmstrøm demonstrates how correlations between NMR data and bioactivity can be used to confirm the structure and activity of proteins.

Join Dr. Yongchao Su for an overview of the versatile roles of ssNMR in pharmaceutical development, providing a structural basis for the design of drug substances and products.

Dr. Sharman explains the impact of using NMR for the quality control and release of drug molecules currently in shortage due to the Coronavirus pandemic.

Experts present key considerations in the design of rigorous preclinical studies in rodent models of muscular dystrophy, including animal model selection, assays and endpoints, and how your results can inform translation to the clinic.

An expert in pharmaceutical sciences discusses solid-state NMR spectroscopy as an advanced analytical technique to provide unique insight into the composition and properties of pharmaceutical formulations.

OBESITY SERIES 2020: Camilla Schéele & Christian Wolfrum discuss the physiology of brown adipose tissue and share late-breaking research on the role of BAT in whole body metabolic regulation.

An expert from AstraZeneca will discuss the use of antibody drugs, how they function and the different techniques used to characterize them in the drug development process.

Scientists discuss the use of NMR to analyze the antiviral drug Azidothymidine AZT, a medication currently used to prevent and treat HIV/AIDS.

Experts discuss how PET/CT imaging can be used to enable image-guided neurointerventions and to study targeted delivery and clearance of therapeutic agents.